Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. - Wikidata - awgldk - TriplyDB

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

http://www.wikidata.org/entity/Q33603682

about

Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma Cells.Characterization of Arabidopsis and rice DWD proteins and their roles as substrate receptors for CUL4-RING E3 ubiquitin ligases.The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.Characteristics of Epstein-Barr virus envelope protein gp42.An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells.beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection.Antibody evasion by a gammaherpesvirus O-glycan shield Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion Molecular virology of Epstein-Barr virus.Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis.Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes.Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.Herpesvirus entry: an update Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.Fusing structure and function: a structural view of the herpesvirus entry machinery.Interaction of human tumor viruses with host cell surface receptors and cell entry The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.Epstein-Barr virus entry.Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B.MUC16/CA125 in the context of modular proteins with an annotated role in adhesion-related processes: in silico analysis.

P2860

Q21090514-C84288B6-7357-4F9F-B4FD-EDE354E99CD4 Q24685733-E51AE807-0A10-4975-9EBC-8C87609E51B8 Q26752331-AB934B22-D5CA-4124-A993-A168FD3A6B91 Q30488509-DADEA984-8AD7-41A6-8F55-942CF7501646 Q31144227-915F78EB-4664-4429-AA5E-62CDC816EACE Q33293521-D89810C8-B9F6-4AA8-BACB-C9A272E4275C Q33640163-8DA481DC-3D10-4219-BA1B-FE50796721BE Q33680515-57DAA9A9-4B6A-4268-ADF5-256A86E7586D Q33790326-ABF7433D-D1D0-4512-9FD7-564C6BD113B0 Q33854424-8E915123-B6C1-4AE4-9A83-638D774F3993 Q33866311-C8F4EB45-9B96-40EE-B78D-922C73F81B4D Q33900772-C3AF31B7-4687-4FDC-A7A4-ED5FD7D760B6 Q33910354-DA640C87-5138-4C3B-A817-D2E3678CED02 Q33910738-A47E6076-F6D1-40C4-A8C6-0CB8A65EF887 Q33918592-E0232E58-C584-422E-B69D-1F24E190F397 Q33984291-95D3A0BD-5FCF-4CBA-B4C7-2C53474BA30F Q33990687-DAFF07D9-B77A-4A8C-B695-383CD2BD323A Q34082672-D37FA3FB-6F25-436B-AF9D-87751BADBBD0 Q34151639-0D7CFB6D-91F7-473C-BBF8-2281A631B436 Q34225554-964195BC-EE17-484C-90B4-F596EE657D9A Q34347652-CAD76733-5046-4F9F-8113-5B093E390165 Q34348276-71D3FDDA-FA09-4269-86F6-FD1A2DA1F984 Q34381037-ECE4A1E2-B3E2-4ECE-9231-2FDC9B3A823C Q34485104-8810A826-3AB0-4DAA-A85A-AF64D3D66433 Q34597080-D2F4D63A-88CA-4CA3-95BD-51ABE2DDBC9B Q34598541-4E59949B-CFA0-4871-A99D-1F0C7C1DFFC9 Q34613494-2075F607-C2F8-4662-AF52-B1D0DA8F274E Q34641914-744E959D-C5B9-4D5D-A16F-66FB7738E9FB Q35101331-E126DD56-57D4-4052-8B40-B5FF79D34549 Q35101353-0FCD09FA-5D82-4DB3-83F8-D0A3317338A0 Q35101434-D1F36600-38F1-4CF6-AE17-F4C4A3505575 Q35115666-EA41E95C-742E-4A4C-9772-79D94814AAE1 Q35217323-CD717C8B-D4C0-459B-9C18-702B54C2AC3B Q35620244-9C159322-5D5A-4F8A-A709-256EEA23F7AF Q35622700-2E5ADCE2-DAC1-403A-A32D-03AA15E7181C Q35676027-26CCF9E6-E153-4358-B1B1-F4187C547DD6 Q35875632-864615D4-5F07-43F7-8727-7F93FE2D4A95 Q35947541-62BBE7CD-18FB-426A-AFD6-BB55360908BC Q36168723-8CD58817-8FE5-41A5-8F93-C2826E09262E Q36202486-A38AC91B-C5CF-4CD3-981E-428B4E9A481B

P2860

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

http://www.wikidata.org/entity/Q33603682

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@ast

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@en

type

label

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@ast

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@en

prefLabel

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@ast

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@en

P1433

Q33603682-5DC5D658-0AD6-4D80-9EF6-5E33E3579282

P1476

Q33603682-DC2188F8-B582-4468-98AC-C11831014BB9

P2093

Q33603682-05DBFC2A-BF30-493E-9BC5-2E925FE87F0B

Q33603682-12556E22-A5AF-4EBB-8D79-F12C7CDFCC32

Q33603682-1526EDBF-5DE7-4559-A7E1-5ADD04926C5F

Q33603682-2748493F-E2E3-4501-999A-AC3A02CA44CF

Q33603682-88B9FF30-96B9-45C0-B4FF-346198AA790B

Q33603682-9E3320C0-6FB1-4127-8AF3-AB075C8381C7

Q33603682-C2EEC4EF-4B36-4751-B2DE-DF93F0D6FDC0

P2860

Q33603682-093487B7-E268-4E8B-8C76-88FF13979692

Q33603682-09D10147-E93A-4079-9A58-4AFCF2186B14

Q33603682-14C7934E-569D-440E-8CB4-365E191B3D58

Q33603682-19681E90-8031-4991-917E-FCFAC9CFDF42

Q33603682-1AD78047-53AD-453C-8223-51D1FC850FB2

Q33603682-1D860405-F71D-43E7-A9A7-49D804467B42

Q33603682-1DB512D5-2AEE-4E65-B917-EB9471134B74

Q33603682-1DF6CF4D-CD99-4227-99E3-456B121B9F47

Q33603682-21E54FD9-FF2D-4F32-8BFA-F8BF2EB82256

Q33603682-2BC62AD3-E3FA-4D70-9AB6-63C8A4E93EC1

P304

Q33603682-9285EDFB-23DD-470F-8D3C-38227E151742

P31

Q33603682-93F63D0E-D42F-4123-ACBF-1CF8DFC019D6

P356

Q33603682-82F020C4-9990-475A-820B-EEA7572A63AD

P433

Q33603682-F1EC7E4D-FDCA-4AF5-BA91-342178961C74

P478

Q33603682-691EA0C3-0ACA-4E13-89E6-24E6EDABA074

P50

Q33603682-823D0EFA-6CF9-4CDF-8A15-871E995358EC

P577

Q33603682-F6F0DD28-633C-4A17-B753-C2F95D311196

P698

Q33603682-1A87DF90-4DAF-4359-83BD-6BFBEBB36380

P921

Q33603682-0E0874F5-C49E-44B6-9A7F-2086491197F7

P932

Q33603682-F619DDA8-1389-49F1-ABAD-39EA7C99ABF8

P356

JVI.74.21.10142-10152.2000

P1433

Journal of Virology

P1476

Infectious Epstein-Barr virus ...... e of additional viral ligands.

@en

P2093

A Janz

http://www.w3.org/2001/XMLSchema#string

C Kurzeder

http://www.w3.org/2001/XMLSchema#string

D Pich

http://www.w3.org/2001/XMLSchema#string

J Mautner

http://www.w3.org/2001/XMLSchema#string

M Kost

http://www.w3.org/2001/XMLSchema#string

M Oezel

http://www.w3.org/2001/XMLSchema#string

W Hammerschmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

Studies on transformation of Escherichia coli with plasmids

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).

Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.

P304

10142-10152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.74.21.10142-10152.2000

http://www.w3.org/2001/XMLSchema#string

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Henri-Jacques Delecluse

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11024143

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

102053

http://www.w3.org/2001/XMLSchema#string